The experimental obesity drug of Amgen Inc shows trends of promising durability in its initial trial
- Dec- 2022 -5 DecemberDH Latest News
The experimental obesity drug of Amgen Inc shows trends of promising durability in its initial trial
Before the data presentation on Saturday, business representatives stated that the experimental obesity medication from Amgen Inc. had shown indications…
Read More »